Abstract:AIMTo construct ltB-ureB fusion gene and its prokaryotic expression system and identify immunity and adjuvanticity of the expressed recombinant protein.METHODSThe ureB gene from a clinical Helicobacter pylori (H pylori) strain Y06 and the ltB gene from Escherichia coli (E. coli) strain 44851 were linked into ltB-ureB fusion gene by PCR. The fusion gene sequence was analyzed after T-A cloning. A prokaryotic recombinant expression vector pET32a inserted with ltB-ureB fusion gene (pET32a-ltB-ureB) was constructed. Expression of the recombinant LTB-UreB protein (rLTB-UreB) in E. coli BL21DE3 induced by isopropylthio-beta-D-galactoside (IPTG) at different concentrations was detected by SDS-PAGE. Western blot assays were used to examine the immunoreaction of rLTB-UreB by a commercial antibody against whole cell of H pylori and a self-prepared rabbit anti-rUreB serum, respectively, and determine the antigenicity of the recombinant protein on inducing specific antibody in rabbits. GM1-ELISA was used to demonstrate the adjuvanticity of rLTB-UreB. Immunoreaction of rLTB-UreB to the UreB antibody positive sera from 125 gastric patients was determined by using ELISA.RESULTSIn comparison with the corresponding sequences of original genes, the nucleotide sequence homologies of the cloned ltB-ureB fusion gene were 100%. IPTG with different dosages of 0.1-1.0 mmol/L could efficiently induce pET32a-ltB-ureB-E.coli BL21DE3 to express the rLTB-UreB. The output of the target recombinant protein expressed by pET32a-ureB-E.coli BL21DE3 was approximately 35% of the total bacterial proteins. rLTB-UreB mainly presented in the form of inclusion body. Western blotting results demonstrated that rLTB-UreB could combine with the commercial antibody against whole cell of H pylori and anti-rUreB serum as well as induce rabbit to produce specific antibody. The strong ability of rLTB-UreB binding bovine GM1 indicated the existence of adjuvanticity of the recombinant protein. All the UreB antibody positive sera from the patients (125/125) were positive for rLTB-UreB.CONCLUSIONA recombinant prokaryotic expression system with high expression efficiency of the target fusion gene ltB-ureB was successfully established. The expressed rLTB-UreB showed qualified immunogenicity, antigenicity and adjuvanticity. All the results mentioned above laid a firm foundation for further development of H pylori genetically engineered vaccine.

Prokaryotic expression and antigenicity analysis of N-terminal fragment of human LBP

Construction of Prokaryotic Expression System of Ltb-Ureb Fusion Gene and Identification of the Recombinant Protein Immunity and Adjuvanticity

Identification and Immunoprotective Effect of Prokaryotic Expression Product of Ltb-Hpaa Fusion Gene

Expression, Purification of Humanized Truncated LBP in Baculovirus Expression Vector System

Prokaryotic Expression of Human L-selectin and Preparation of Polyclonal Antibody

[Construction of Human Phage Antibody Library and Screening and Characterization of Phage Antibodies Against N Terminal Fragment of Human Lipopolysaccharide Binding Protein].

Cloning and Expression of Fragment with 2148 Bp from Caga Gene from Isolates of a Helicobacter Pylori and Identification of Immunogenicity of the Recombinant Proteins

Expression,purification and Immunogenicity of a Partial Fragment of Anthrax Neutral Protease

Expression of T and B cells combined epitopes protein of Leptospira interrogans and the immunity analysis

Prokaryotic Expression and Identification of FABP Gene from Echinococcus granulosus

Prokaryotic Expression Purification and Identification of Human Amino-Terminal Pro-Brain Natriuretic Peptide and Its Stability

Prokaryotic Expression and Purification of L7/L12 Protein of B.abortus

Analysis of antigenicity in four antigenic candidate genes of Lawsonia intracellularis GXNN strain

Gene Cloning,Prokaryotic Expression and Immunogenicity of 67kda Laminin Receptor Precursor(LRP)

Prokaryotic expression and bioactivity identification of hemolysin from Listeria monocytogenes

Expression, Purification and Identification of Human N Terminal Lipopolysaccharide Binding Protein by Insect Sf21 or Sf9 Cells

Prokaryotic Expression of Lysostaphin and Preparation of Its Polyclonal Antibody

Prokaryotic expression and preparation of polyclonal antibody of NGAL

Expression and Purification of Soluble Human Neutrophil Gelatinase Associated Lipocalin in E.coli

Preparation of Antiserums Against Chicken Liver-type Fatty Acid Binding Protein (L-FABP) and Tissue Expression Analyses of L-FABP

Establishment of prokar yotic expression system of autoantigen human bactericidal/permeability-incre-asing fold-containing B1